3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
7
Head & Neck
3
Breast
3
Thoracic
2
Sarcoma
2
Gynecologic
2
Gastrointestinal
2
Myeloid
1
Lymphoid
1
Dermatologic
1
CNS
1
Conditions
Colorectal Neoplasms
302
Pancreatic Neoplasms
182
Carcinoma, Hepatocellular
113
Stomach Neoplasms
109
Breast Neoplasms
78
Colonic Neoplasms
77
Esophageal Neoplasms
76
Carcinoma, Non-Small-Cell Lung
75
Rectal Neoplasms
74
Ovarian Neoplasms
62
Lung Neoplasms
59
Neoplasm Metastasis
54
Neoplasms
53
Cholangiocarcinoma
49
Liver Neoplasms
47
Melanoma
45
Prostatic Neoplasms
42
Gastrointestinal Neoplasms
39
Biliary Tract Neoplasms
38
Endometrial Neoplasms
34
Squamous Cell Carcinoma of Head and Neck
31
Sarcoma
31
Carcinoma, Renal Cell
28
Esophageal Squamous Cell Carcinoma
27
Uterine Cervical Neoplasms
25
Adenocarcinoma Of Esophagus
25
Urinary Bladder Neoplasms
22
Head and Neck Neoplasms
22
Anus Neoplasms
19
Gastrointestinal Stromal Tumors
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Urologic Neoplasms
×
Gastrointestinal
×
30 days
×
Clear all
NCT06238479
2026-05-22
EXCEED
Eli Lilly and Company
Phase 1
Active not recruiting
490 enrolled
NCT06465069
2026-05-22
NEXUS-01
Eli Lilly and Company
Phase 1
Recruiting
420 enrolled